Elevance Health (ELV) DIvidends Date & History

Key Takeaways

• Elevance Health (ELV) pays a quarterly dividend of $1.72 per share, totaling $6.88 annually, with a forward dividend yield of approximately 1.78%.
• The company has raised its dividend for 14 consecutive years, supported by a five-year compound annual growth rate (CAGR) of roughly 12.5%.
• The payout ratio stands at approximately 29% of trailing earnings and roughly 18% of free cash flow, signaling strong dividend coverage and ample room for future increases.
• ELV's dividend yield sits below the managed healthcare industry average but is backed by superior dividend growth consistency and a conservative payout structure.
• The stock may appeal primarily to dividend growth investors and long-term total return seekers rather than those pursuing high current income.

Dividend Overview

ELV, the parent company of Elevance Health — one of the largest health insurers in the United States and the largest licensee of Blue Cross Blue Shield plans across 14 states — maintains a disciplined quarterly dividend policy. The company currently distributes $1.72 per share each quarter, bringing the annualized dividend to $6.88 per share. Based on recent trading levels, the forward dividend yield hovers around 1.78%. Elevance Health is best characterized as a dividend growth stock rather than a high-yield play. Its yield, while modest compared to some income-oriented sectors, reflects a management philosophy centered on sustainable, compounding dividend increases rather than maximizing near-term payouts. The most recent ex-dividend date was June 10, 2026, with the subsequent payment made on June 25, 2026. Investors can expect the next quarterly declaration in the coming months, consistent with the company's established March-June-September-December cycle.

Dividend History and Growth

Elevance Health has built an impressive track record of dividend reliability. The company has increased its dividend every year for 14 consecutive years, placing it among a select group of healthcare companies with double-digit growth streaks. Since initiating its modern dividend growth trajectory in 2012, the quarterly payout has climbed from $0.2875 per share to $1.72 per share — a roughly sixfold increase over approximately 15 years. The five-year dividend CAGR stands at approximately 12.47%, while the ten-year CAGR is roughly 10.2%. Recent annual increases have been more measured: the dividend rose from $1.63 per quarter in 2024 to $1.71 in 2025, and then to $1.72 in early 2026. This moderation in the pace of increases reflects a maturing capital allocation framework, but the consistency of the growth streak underscores management's commitment to returning capital to shareholders through thick and thin, including during the COVID-19 pandemic when many peers paused or cut their dividends.

Dividend Sustainability and Payout Ratio

One of the most compelling features of Elevance Health's dividend profile is its extremely conservative payout ratio. Based on trailing twelve-month earnings, the payout ratio sits at approximately 29%, well below the 50-60% threshold generally considered sustainable for mature companies in the managed care industry. When measured against free cash flow, the ratio is even lower at roughly 18%, indicating that the dividend consumes only a small fraction of the company's cash-generating capacity. Elevance Health's earnings per share (EPS) have remained robust, supported by membership growth across its commercial, Medicare Advantage, and Medicaid segments, as well as expanding contributions from its Carelon health services platform. The company maintains a solid balance sheet with manageable debt levels relative to its earnings before interest, taxes, depreciation, and amortization (EBITDA), providing ample financial flexibility to sustain and grow the dividend even during periods of elevated medical costs or regulatory headwinds. This low payout ratio also leaves significant room for share buybacks, which the company regularly executes, further enhancing total shareholder returns.

Dividend Compared to Industry Peers

Within the managed healthcare sector, Elevance Health's dividend yield of roughly 1.78% is positioned on the lower end of the peer spectrum. UNH (UnitedHealth Group) offers a yield around 2.17% to 3.10%, while CI (The Cigna Group) yields approximately 2.20% to 2.27%. CVS (CVS Health) stands out with a higher yield near 3.51%, though it carries a different risk profile given its pharmacy and retail exposure. HUM (Humana) provides a yield around 2.08%, while CNC (Centene) does not currently pay a dividend. What Elevance Health may lack in current yield it partially compensates for with superior dividend growth consistency: its 14-year growth streak and five-year dividend CAGR of approximately 12.5% outpace several peers. Moreover, ELV's payout ratio of roughly 29% is among the lowest in the group, suggesting more headroom for future increases compared to UnitedHealth, whose payout ratio has drifted higher toward the 67% range.

AI Screener

For investors seeking to identify dividend-paying stocks like Elevance Health alongside emerging opportunities across the broader market, the AI Screener from Tickeron offers a powerful AI-driven solution. This advanced screening tool enables traders and investors to filter thousands of stocks and ETFs using customizable criteria, including industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and fundamental data points. The AI Screener is particularly useful for income-focused investors looking to scan for dividend stocks based on yield thresholds, payout ratios, and dividend growth streaks. It also helps surface breakout candidates, trending equities, and stocks exhibiting specific technical formations — all with greater speed and precision than manual screening. Whether you are building a dividend growth portfolio or scanning for tactical opportunities, the AI Screener streamlines the discovery process.

Is This Stock Attractive for Dividend Investors?

Elevance Health (ELV) presents a nuanced proposition for dividend investors. The stock is not an ideal fit for pure income seekers who depend on high current yields to meet living expenses; its roughly 1.78% yield falls well short of what income-oriented alternatives such as REITs (Real Estate Investment Trusts), utilities, or high-yield fixed income can provide. However, for dividend growth investors with a multi-year horizon, ELV offers a compelling combination of a rock-solid payout ratio, a long history of annual increases, and double-digit five-year dividend growth. Long-term total return investors may also find the stock appealing, as the low payout ratio and strong free cash flow generation support both dividend growth and share repurchases, which together can drive meaningful per-share value creation over time. Conservative investors who prioritize balance sheet strength and payout reliability over maximum yield will appreciate Elevance Health's disciplined capital allocation approach. That said, the managed care sector carries regulatory and political risks — changes to Medicare Advantage reimbursement rates, Medicaid eligibility rules, or the broader healthcare policy landscape can impact profitability and, by extension, dividend policy. Investors should weigh these factors within the context of their own financial goals and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations